Showing 71 - 80 of 129
Persistent link: https://www.econbiz.de/10008237822
Persistent link: https://www.econbiz.de/10007764370
Persistent link: https://www.econbiz.de/10008090317
Persistent link: https://www.econbiz.de/10008899288
Persistent link: https://www.econbiz.de/10012881698
Patents for several blockbuster biological products are expected to expire soon. The Food and Drug Administration is examining whether biologics can and should be treated like pharmaceuticals with regard to generics. In contrast with pharmaceuticals, which are manufactured through chemical...
Persistent link: https://www.econbiz.de/10014049980
We analyze how rewards and penalties for follow-on drugs affect innovation, profits, and social welfare. Examples of policies that reduce the rate of return for follow-on drugs include the Orphan Drug Act and standard review at FDA, as well as the proposal of the former editor of the New England...
Persistent link: https://www.econbiz.de/10014049981
Persistent link: https://www.econbiz.de/10005708237
Theory predicts intense price competition results when firms cluster with rivals. Yet, strong evidence of clustering is found in previous empirical research. Researchers typically measure clustering by comparing observed location patterns to random assignment. The random assignment benchmark...
Persistent link: https://www.econbiz.de/10004973816
"Why do businesses such as fast-food restaurants, coffee shops, and hotels cluster? In the classic analysis of Hotelling, firms cluster to attract consumers who have travel costs. We present an alternative model where firms cluster because one firm is free riding on another firm's information...
Persistent link: https://www.econbiz.de/10005679266